Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis
Vorhersage des Ansprechens auf platinbasierte Chemotherapie bei Ovarialkarzinom mithilfe von Machine Learning: systematische Übersichtsarbeit und Metaanalyse
Journal of Medical Internet Research · 2024-01-22 · 26 · e48527
DOI: 10.2196/48527 ↗Auf einen Blick
19 Studien mit 39 Modellen: Machine-Learning-Modelle sagten das Ansprechen auf platinbasierte Chemotherapie bei Ovarialkarzinom mit guter Leistung vorher. Die gepoolten C-Index-Werte lagen bei 0,806 und 0,831.
Fragestellung
Wie gut sagen Machine-Learning-Modelle das Ansprechen auf platinbasierte Chemotherapie bei Patientinnen mit Ovarialkarzinom voraus?
Methode
Systematische Übersichtsarbeit und Metaanalyse nach PRISMA; Suche in PubMed, Embase, Web of Science und Cochrane bis 26. April 2023; Bewertung mit Prediction Model Risk of Bias Assessment Tool.
Ergebnisse
19 von 1.749 Artikeln waren geeignet, mit 39 Modellen. Gepoolter C-Index: 0,806 im Trainingskohorten und 0,831 im Validierungskohorten; SVM: 0,942 und 0,879. Gepoolte Sensitivität 0,890, Spezifität 0,790 im Training.
Schlussfolgerung der Autor:innen
Machine Learning kann das Ansprechen auf platinbasierte Chemotherapie bei Ovarialkarzinom wirksam vorhersagen und könnte als Referenz für die Entwicklung oder Aktualisierung künftiger Scores dienen.
Kernaussagen
- 39 Vorhersagemodelle aus 19 Studien
- Gepoolter C-Index: 0,806 Training; 0,831 Validierung
- SVM erzielte C-Index-Werte von 0,942 und 0,879
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Metaanalyse in Journal of Medical Internet Research, published online on 2024-01-22. Written by Qingyi Wang and 6 co-authors. Institution: Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China. Major MEDLINE topics: Ovarian Neoplasms. Cited 25 times so far (Crossref); 62 references. The full text is freely available in PubMed Central.
Topics: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (original language)
Background
Machine learning is a potentially effective method for predicting the response to platinum-based treatment for ovarian cancer. However, the predictive performance of various machine learning methods and variables is still a matter of controversy and debate.
Objective
This study aims to systematically review relevant literature on the predictive value of machine learning for platinum-based chemotherapy responses in patients with ovarian cancer.
Methods
Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we systematically searched the PubMed, Embase, Web of Science, and Cochrane databases for relevant studies on predictive models for platinum-based therapies for the treatment of ovarian cancer published before April 26, 2023. The Prediction Model Risk of Bias Assessment tool was used to evaluate the risk of bias in the included articles. Concordance index (C-index), sensitivity, and specificity were used to evaluate the performance of the prediction models to investigate the predictive value of machine learning for platinum chemotherapy responses in patients with ovarian cancer.
Results
A total of 1749 articles were examined, and 19 of them involving 39 models were eligible for this study. The most commonly used modeling methods were logistic regression (16/39, 41%), Extreme Gradient Boosting (4/39, 10%), and support vector machine (4/39, 10%). The training cohort reported C-index in 39 predictive models, with a pooled value of 0.806; the validation cohort reported C-index in 12 predictive models, with a pooled value of 0.831. Support vector machine performed well in both the training and validation cohorts, with a C-index of 0.942 and 0.879, respectively. The pooled sensitivity was 0.890, and the pooled specificity was 0.790 in the training cohort.
Conclusions
Machine learning can effectively predict how patients with ovarian cancer respond to platinum-based chemotherapy and may provide a reference for the development or updating of subsequent scoring systems.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
- Basic Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
- Department of Gynecology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
ORCID profiles: Qingyi Wang, Zhuo Chang, Xiaofang Liu, Yunrui Wang, Chuwen Feng, Yunlu Ping, Xiaoling Feng
Cite
APA
Wang, Q., Chang, Z., Liu, X., Wang, Y., Feng, C., Ping, Y., & Feng, X. (2024). Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 26, e48527. https://doi.org/10.2196/48527
Vancouver
Wang Q, Chang Z, Liu X, Wang Y, Feng C, Ping Y, et al. Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2024;26:e48527. doi:10.2196/48527
BibTeX
@article{Wang2024,
author = {Wang, Qingyi and Chang, Zhuo and Liu, Xiaofang and Wang, Yunrui and Feng, Chuwen and Ping, Yunlu and Feng, Xiaoling},
title = {Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis},
journal = {Journal of Medical Internet Research},
year = {2024},
volume = {26},
pages = {e48527},
doi = {10.2196/48527}
}
EUVIMED